Biogen Idec Inc
Latest News
-
Orbimed's $3.4B Filing: 2 Stocks It And Other Healthcare Funds Bought In Q1, And Other Trades
— May 24 2012 6:32 PM from Seeking Alpha -
Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status
— May 23 2012 1:34 PM from PR Newswire -
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent
— May 23 2012 12:09 PM from Business Wire -
AVEO Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors
— May 23 2012 10:36 AM from Business Wire -
The Technical Indicator: Charting the corrective bounce
— May 22 2012 4:10 PM from MarketWatch
